Octant
Johan has spent the last 7 years in biotech working with metabolic disease and weight loss. As an employee of Carmot Therapeutics Johan spearheaded the in vivo pharmacology effort, establishing all in vivo models necessary to push an in house project from inception to Phase 1 clinical trials.
Johan spent his early education getting an MSc in cell and molecular pharmacology at Lund University (1999), with a focus on intracellular movements of GPCRs. Johan followed up his MSc with a PhD from Lund University (2007) extending his studies from his undergraduate degree in GPCR pharmacology - exploring several families of GPCRs. During his postdoctoral fellowship at UCSF (2007-2013) Johan applied his findings from his MSc and PhD to animal models of addiction and tolerance, learning crucial methodology in physiological and behavioral readouts in rodent models, drug delivery and survival surgery techniques.
Along the way Johan has taught medical and biomedical students (lecture series), trained research students, technical staff and scientists, and managed technical staff and scientists in cross functional research teams in both academia and biotech.
This person is not in any offices
Octant
2 followers
Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology. We are applying next-generation DNA sequencing, gene synthesis, and gene editing to revolutionize drug discovery in a quest for safer, more effective, and cheaper drugs.